XML 43 R17.htm IDEA: XBRL DOCUMENT
v3.19.2

Note 10 - Loss Per Common Share | 6 Months Ended
--- | ---
Jun. 30, 2019
Notes to Financial Statements |
Earnings Per Share [Text Block] |
10. | Loss Per Common Share:
All shares issued (including non-vested shares issued under the Company’s stock incentive plans) are the Company's common stock and have equal rights to vote and participate in dividends and in undistributed earnings. Non-vested shares do not have a contractual obligation to share in the losses. For purposes of calculating diluted earnings per share the denominator of the diluted earnings per share calculation includes:
| • | the potential dilution that could occur if 2014 Warrants were exercised, to the extent that they are dilutive, using the treasury stock method,
| • | the potential dilution that could occur if Series E Shares were converted (see Note 12 ), using the if-converted method weighted for the period the Series E Shares were outstanding, and
The components of the calculation of basic and diluted earnings per share for the periods ended June 30, 2018 and 2019 are as follows:
|  | Six months ended June 30,
|  | 2018 |  | 2019
Income: |  |  |  |  |  |  |  |
Loss attributable to common shareholders |  |  | (6,624 | ) |  |  | (628 | )
Less: Deemed dividend for beneficial conversion feature of Series E Shares |  |  | - |  |  |  | (9,339 | )
Less: Dividend equivalents on Series E Shares related to redemption value |  |  | - |  |  |  | (4,223 | )
Less: Dividend of Series E Shares |  |  | - |  |  |  | (1,029 | )
Loss attributable to common shareholders |  |  | (6,624 | ) |  |  | (15,219 | )
Loss per share: |  |  |  |  |  |  |  |
Weighted average common shares outstanding, basic |  |  | 781,027 |  |  |  | 1,313,102 |
Effect of dilutive securities: |  |  |  |  |  |  |  |
2014 Warrants |  |  | - |  |  |  | - |
Series E Shares |  |  | - |  |  |  | - |
Weighted average common shares outstanding, diluted |  |  | 781,027 |  |  |  | 1,313,102 |
Loss per share, basic and diluted |  |  | (8.48 | ) |  |  | (11.59 | )
The following table summarizes the securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive even though the exercise or conversion price could be less than the average market price of the common shares.
|  | Six months ended June 30,
|  | 2018 |  | 2019
2014 Warrants |  |  | - |  |  |  | 71,533 |
Series E Shares |  |  | - |  |  |  | 1,135,488 |
Potentially dilutive securities |  |  | - |  |  |  | 1,207,021 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration